PATENT CLAIM ANALYSIS

Application Number: 16244467
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "255000"]

Abstract:
Disclosed are compounds useful as inhibitors of the Wnt signalling pathway. Specifically, inhibitors of Porcupine (Porcn) are contemplated by the invention. In addition, the invention contemplates processes to prepare the compounds and uses of the compounds. The compounds of the invention may therefore be used in treating conditions mediated by the Wnt signalling pathway, for example, in treating cancer, sarcoma, melanoma, skin cancer, haematological tumors, lymphoma, carcinoma, and leukemia; or enhancing the effectiveness of an anti-cancer treatment.

Claim (Index 42):
The pharmaceutical formulation of  claim 29 , wherein R 3  is H or methyl.

Metadata:
- Claim Count in Document: 104.0
- Percentile: 99.0
- Lexical Diversity: 1.69643
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15514061', '15514046', '14893691', '15509952', '15580978']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8168840060578164
- 35 USC 102 Novelty (BERT): 0.5861408354737602
- Combined Prediction Score: 0.7938096889994108
- Mean Citation Score: 382.794848
- Max Citation Score: 535.7033700000002
- Similarity Product: 404.2532517675395

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test